These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10032574)

  • 1. The sdg interacting-boson model applied to 168Er.
    Yoshinaga N; Akiyama Y; Arima A
    Phys Rev Lett; 1986 Mar; 56(11):1116-1119. PubMed ID: 10032574
    [No Abstract]   [Full Text] [Related]  

  • 2. sdg interacting-boson model in the SU(3) scheme and its application to 168Er.
    Yoshinaga N; Akiyama Y; Arima A
    Phys Rev C Nucl Phys; 1988 Jul; 38(1):419-436. PubMed ID: 9954815
    [No Abstract]   [Full Text] [Related]  

  • 3. Simple model for deriving sdg interacting boson model Hamiltonians: 150Nd example.
    Devi YD; Kota VK
    Phys Rev C Nucl Phys; 1993 Jul; 48(1):461-464. PubMed ID: 9968847
    [No Abstract]   [Full Text] [Related]  

  • 4. E4 properties in deformed nuclei and the sdg interacting boson model.
    Wu HC; Dieperink AE; Scholten O; Harakeh MN; De Leo R ; Pignanelli M; Morrison I
    Phys Rev C Nucl Phys; 1988 Oct; 38(4):1638-1648. PubMed ID: 9954975
    [No Abstract]   [Full Text] [Related]  

  • 5. M1 excitation in Sm isotopes and the proton-neutron sdg interacting boson model.
    Mizusaki T; Otsuka T; Sugita M
    Phys Rev C Nucl Phys; 1991 Oct; 44(4):R1277-R1280. PubMed ID: 9967597
    [No Abstract]   [Full Text] [Related]  

  • 6. Spectroscopy of samarium isotopes in the sdg interacting boson model.
    Devi YD; Kota VK
    Phys Rev C Nucl Phys; 1992 May; 45(5):2238-2246. PubMed ID: 9967984
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on "Spectroscopy of samarium isotopes in the sdg interacting boson model".
    Kuyucak S; Lac VS
    Phys Rev C Nucl Phys; 1993 Apr; 47(4):1815-1818. PubMed ID: 9968631
    [No Abstract]   [Full Text] [Related]  

  • 8. beta 4 systematics in rare-earth and actinide nuclei: sdg interacting boson model description.
    Devi YD; Kota VK
    Phys Rev C Nucl Phys; 1992 Jul; 46(1):370-373. PubMed ID: 9968119
    [No Abstract]   [Full Text] [Related]  

  • 9. Critical-point symmetries in boson-fermion systems: the case of shape transitions in odd nuclei in a multiorbit model.
    Alonso CE; Arias JM; Vitturi A
    Phys Rev Lett; 2007 Feb; 98(5):052501. PubMed ID: 17358851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration kinetics of secoisolariciresinol diglucoside and its biosynthetic precursor coniferin in developing flaxseed.
    Fang J; Ramsay A; Paetz C; Tatsis EC; Renouard S; Hano C; Grand E; Fliniaux O; Roscher A; Mesnard F; Schneider B
    Phytochem Anal; 2013; 24(1):41-6. PubMed ID: 22689568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signature of g boson in the interacting-boson model from g-factor variations.
    Kuyucak S; Morrison I
    Phys Rev Lett; 1987 Jan; 58(4):315-317. PubMed ID: 10034902
    [No Abstract]   [Full Text] [Related]  

  • 12. Mean-field derivation of the interacting boson model Hamiltonian and exotic nuclei.
    Nomura K; Shimizu N; Otsuka T
    Phys Rev Lett; 2008 Oct; 101(14):142501. PubMed ID: 18851521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "Signature of g boson in the interacting-boson model from g-factor variations".
    Cohen TD
    Phys Rev Lett; 1987 Aug; 59(5):605. PubMed ID: 10035820
    [No Abstract]   [Full Text] [Related]  

  • 14. Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury.
    Penumathsa SV; Koneru S; Thirunavukkarasu M; Zhan L; Prasad K; Maulik N
    J Pharmacol Exp Ther; 2007 Feb; 320(2):951-9. PubMed ID: 17132814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying a bath-induced bose liquid in interacting spin-boson models.
    Cai Z; Schollwöck U; Pollet L
    Phys Rev Lett; 2014 Dec; 113(26):260403. PubMed ID: 25615290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum phases in a resonantly interacting boson-fermion mixture.
    Dickerscheid DB; van Oosten D; Tillema EJ; Stoof HT
    Phys Rev Lett; 2005 Jun; 94(23):230404. PubMed ID: 16090448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landau theory of shape phase transitions in the cranked interacting boson model.
    Cejnar P
    Phys Rev Lett; 2003 Mar; 90(11):112501. PubMed ID: 12688923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantum dynamics of strongly interacting boson systems: atomic beam splitters and coupled Bose-Einstein condensates.
    Bogoliubov NM; Izergin AG; Kitanine NA; Pronko AG; Timonen J
    Phys Rev Lett; 2001 May; 86(20):4439-42. PubMed ID: 11384254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of impaired glucose tolerance on atherosclerotic lesion formation: an evaluation in selectively bred mice with different susceptibilities to glucose intolerance.
    Asai A; Nagao M; Kawahara M; Shuto Y; Sugihara H; Oikawa S
    Atherosclerosis; 2013 Dec; 231(2):421-6. PubMed ID: 24267261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, characterization and antihyperlipidemic activity of secoisolariciresinol diglucoside in poloxamer-407-induced experimental hyperlipidemia.
    Zanwar AA; Hegde MV; Rojatkar SR; Sonawane KB; Rajamohanan PR; Bodhankar SL
    Pharm Biol; 2014 Sep; 52(9):1094-103. PubMed ID: 24649910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.